Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT

Zachariah DeFilipp, Rafael F. Duarte, John A. Snowden, Navneet S. Majhail, Diana M. Greenfield, Jose Lopez Miranda, Mutlu Arat, K. Scott Baker, Linda J. Burns, Christine N. Duncan, Maria Gilleece, Gregory A. Hale, Mehdi Hamadanin, Betty K. Hamilton, William J. Hogan, Jack W. Hsu, Yoshihiro Inamoto, Rammurti T. Kamble, Maria Teresa Lupo-Stanghellini, Adriana K. MalonePhilip L. McCarthy, Mohamad Mohty, Maxim Norkin, Pamela Paplham, Muthalagu Ramanathan, John M. Richart, Nina Salooja, Hendricus Schouten, Helene Schoemans, Adriana Seber, Amir Steinberg, Baldeep M. Wirk, William A. Wood, Minoo Battiwalla, Mary E. D. Flowers, Bipin N. Savani, Bronwen E. Shaw*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1493-1503
JournalBiology of Blood and Marrow Transplantation
Volume22
Issue number8
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Metabolic syndrome
  • Cardiovascular disease
  • Hematopoietic cell transplantation
  • Survivorship
  • Late effects

Cite this